We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advaxis’ Cervical Cancer Immunotherapy Sees Survival Improvement
Advaxis’ Cervical Cancer Immunotherapy Sees Survival Improvement
A trial of a cervical cancer treatment by New Jersey biotech company Advaxis demonstrated it could extend life further than existing treatments in women with persistent, advanced forms of the disease.